ATE286057T1 - Pharmazeutische zubereitungen enthaltend clavulansäure - Google Patents
Pharmazeutische zubereitungen enthaltend clavulansäureInfo
- Publication number
- ATE286057T1 ATE286057T1 AT01987751T AT01987751T ATE286057T1 AT E286057 T1 ATE286057 T1 AT E286057T1 AT 01987751 T AT01987751 T AT 01987751T AT 01987751 T AT01987751 T AT 01987751T AT E286057 T1 ATE286057 T1 AT E286057T1
- Authority
- AT
- Austria
- Prior art keywords
- clavulanic acid
- pharmaceutical preparations
- preparations containing
- containing clavulanic
- mum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
- C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
- C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
- C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT18062000 | 2000-10-20 | ||
PCT/EP2001/012076 WO2002032906A1 (en) | 2000-10-20 | 2001-10-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE286057T1 true ATE286057T1 (de) | 2005-01-15 |
Family
ID=3689001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01987751T ATE286057T1 (de) | 2000-10-20 | 2001-10-18 | Pharmazeutische zubereitungen enthaltend clavulansäure |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040043981A1 (de) |
EP (1) | EP1328528B1 (de) |
JP (2) | JP2004511561A (de) |
KR (1) | KR20030069995A (de) |
CN (1) | CN1267437C (de) |
AT (1) | ATE286057T1 (de) |
AU (1) | AU2002221702A1 (de) |
CA (1) | CA2424462C (de) |
DE (1) | DE60108154T2 (de) |
ES (1) | ES2234919T3 (de) |
MX (1) | MXPA03003312A (de) |
PL (1) | PL360254A1 (de) |
WO (1) | WO2002032906A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7295509B2 (en) | 2000-09-13 | 2007-11-13 | Qualcomm, Incorporated | Signaling method in an OFDM multiple access system |
US9130810B2 (en) | 2000-09-13 | 2015-09-08 | Qualcomm Incorporated | OFDM communications methods and apparatus |
US9246560B2 (en) | 2005-03-10 | 2016-01-26 | Qualcomm Incorporated | Systems and methods for beamforming and rate control in a multi-input multi-output communication systems |
US9154211B2 (en) | 2005-03-11 | 2015-10-06 | Qualcomm Incorporated | Systems and methods for beamforming feedback in multi antenna communication systems |
US8446892B2 (en) | 2005-03-16 | 2013-05-21 | Qualcomm Incorporated | Channel structures for a quasi-orthogonal multiple-access communication system |
US9143305B2 (en) | 2005-03-17 | 2015-09-22 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9520972B2 (en) | 2005-03-17 | 2016-12-13 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9184870B2 (en) | 2005-04-01 | 2015-11-10 | Qualcomm Incorporated | Systems and methods for control channel signaling |
US9036538B2 (en) | 2005-04-19 | 2015-05-19 | Qualcomm Incorporated | Frequency hopping design for single carrier FDMA systems |
US9408220B2 (en) | 2005-04-19 | 2016-08-02 | Qualcomm Incorporated | Channel quality reporting for adaptive sectorization |
US8879511B2 (en) | 2005-10-27 | 2014-11-04 | Qualcomm Incorporated | Assignment acknowledgement for a wireless communication system |
US8462859B2 (en) | 2005-06-01 | 2013-06-11 | Qualcomm Incorporated | Sphere decoding apparatus |
US9179319B2 (en) | 2005-06-16 | 2015-11-03 | Qualcomm Incorporated | Adaptive sectorization in cellular systems |
US8599945B2 (en) | 2005-06-16 | 2013-12-03 | Qualcomm Incorporated | Robust rank prediction for a MIMO system |
US8885628B2 (en) | 2005-08-08 | 2014-11-11 | Qualcomm Incorporated | Code division multiplexing in a single-carrier frequency division multiple access system |
US9209956B2 (en) | 2005-08-22 | 2015-12-08 | Qualcomm Incorporated | Segment sensitive scheduling |
US8644292B2 (en) | 2005-08-24 | 2014-02-04 | Qualcomm Incorporated | Varied transmission time intervals for wireless communication system |
US9136974B2 (en) | 2005-08-30 | 2015-09-15 | Qualcomm Incorporated | Precoding and SDMA support |
US8045512B2 (en) | 2005-10-27 | 2011-10-25 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US8477684B2 (en) | 2005-10-27 | 2013-07-02 | Qualcomm Incorporated | Acknowledgement of control messages in a wireless communication system |
US9225416B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Varied signaling channels for a reverse link in a wireless communication system |
US9144060B2 (en) | 2005-10-27 | 2015-09-22 | Qualcomm Incorporated | Resource allocation for shared signaling channels |
US8582509B2 (en) | 2005-10-27 | 2013-11-12 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US9225488B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Shared signaling channel |
US9088384B2 (en) | 2005-10-27 | 2015-07-21 | Qualcomm Incorporated | Pilot symbol transmission in wireless communication systems |
US9210651B2 (en) | 2005-10-27 | 2015-12-08 | Qualcomm Incorporated | Method and apparatus for bootstraping information in a communication system |
US8693405B2 (en) | 2005-10-27 | 2014-04-08 | Qualcomm Incorporated | SDMA resource management |
KR20120012823A (ko) * | 2009-04-29 | 2012-02-10 | 렉산 파마슈티컬스, 인코포레이티드 | 신경보호 및 퇴행성 신경 질환 치료용 클라블라네이트 제제 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US29038A (en) * | 1860-07-03 | George a | ||
NZ189022A (en) * | 1977-12-08 | 1981-11-19 | Beecham Group Ltd | Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder |
US5288861A (en) * | 1987-01-29 | 1994-02-22 | Beecham Group Plc | Potassium clavulanate in rosette form |
US5750685A (en) * | 1987-01-29 | 1998-05-12 | Smithkline Beecham, P.L.C. | Process for preparing potassium clavulanate in rossette form |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
AT403375B (de) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | Verfahren zur fällung von alkalisalzen der clavulansäure |
AT404728B (de) * | 1996-11-27 | 1999-02-25 | Biochemie Gmbh | Verfahren zur herstellung von clavulansäure-aminsalzen |
ATE260096T1 (de) * | 1999-04-01 | 2004-03-15 | Dsm Ip Assets Bv | Agglomerate durch kristallisation |
-
2001
- 2001-10-18 CA CA2424462A patent/CA2424462C/en not_active Expired - Lifetime
- 2001-10-18 DE DE60108154T patent/DE60108154T2/de not_active Expired - Lifetime
- 2001-10-18 PL PL01360254A patent/PL360254A1/xx unknown
- 2001-10-18 MX MXPA03003312A patent/MXPA03003312A/es active IP Right Grant
- 2001-10-18 EP EP01987751A patent/EP1328528B1/de not_active Expired - Lifetime
- 2001-10-18 US US10/399,427 patent/US20040043981A1/en not_active Abandoned
- 2001-10-18 WO PCT/EP2001/012076 patent/WO2002032906A1/en active IP Right Grant
- 2001-10-18 CN CNB018175538A patent/CN1267437C/zh not_active Expired - Lifetime
- 2001-10-18 AT AT01987751T patent/ATE286057T1/de active
- 2001-10-18 KR KR10-2003-7004308A patent/KR20030069995A/ko active Search and Examination
- 2001-10-18 AU AU2002221702A patent/AU2002221702A1/en not_active Abandoned
- 2001-10-18 JP JP2002536287A patent/JP2004511561A/ja active Pending
- 2001-10-18 ES ES01987751T patent/ES2234919T3/es not_active Expired - Lifetime
-
2009
- 2009-05-01 JP JP2009112262A patent/JP2009197020A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2009197020A (ja) | 2009-09-03 |
KR20030069995A (ko) | 2003-08-27 |
CN1469880A (zh) | 2004-01-21 |
JP2004511561A (ja) | 2004-04-15 |
DE60108154D1 (de) | 2005-02-03 |
CA2424462C (en) | 2010-03-30 |
EP1328528B1 (de) | 2004-12-29 |
CN1267437C (zh) | 2006-08-02 |
EP1328528A1 (de) | 2003-07-23 |
MXPA03003312A (es) | 2004-12-03 |
US20040043981A1 (en) | 2004-03-04 |
CA2424462A1 (en) | 2002-04-25 |
WO2002032906A1 (en) | 2002-04-25 |
PL360254A1 (en) | 2004-09-06 |
ES2234919T3 (es) | 2005-07-01 |
DE60108154T2 (de) | 2005-12-22 |
AU2002221702A1 (en) | 2002-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE286057T1 (de) | Pharmazeutische zubereitungen enthaltend clavulansäure | |
YU49698A (sh) | Smeše koje sadrže tetrahidrolipstatin | |
FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
HUP0203556A2 (hu) | Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk | |
GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
DE69802260D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen | |
ES2190075T3 (es) | Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico. | |
CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
EA200300081A1 (ru) | Гидрогель-управляемая лекарственная форма | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
ATE214610T1 (de) | Neuartige pharmazeutische verwendungen von krill- enzymen | |
IT1301966B1 (it) | Composizioni farmaceutiche ad attivita' analgesica | |
DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
FR2774687B1 (fr) | Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques | |
ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
DE60112756D1 (de) | Racecadotril enthaltende trockene pulverformulierung | |
DE60137069D1 (de) | Arzneizusammensetzungen enthaltend modafinilverbindungen | |
TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
PT1228039E (pt) | N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas | |
EP1269978A3 (de) | Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen | |
SE0001916D0 (sv) | Novel formulation | |
RS50345B (sr) | Vodena farmaceutska kompozicija koja sadrži ciklesonid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1328528 Country of ref document: EP |